Clinical trials
Completed Hypertension, Pulmonary trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| Shanghai Jiao Tong University School of Medicine | 4 |
| United Therapeutics | 3 |
| Wei Huang | 2 |
| Actelion | 1 |
| Association for Pediatric Pulmonary Hypertension | 1 |
| AstraZeneca | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 28 |
| Pulmonary Arterial Hypertension | 8 |
| Heart Failure | 3 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Bronchiectasis | 1 |
| Cardiovascular Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Disease | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Defects, Congenital | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.